Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome
Abstract We aimed to evaluate the effect of baseline low-density lipoprotein cholesterol (LDL-C) on the outcomes of patients with the acute coronary syndrome (ACS) receiving pitavastatin monotherapy or the combination of pitavastatin + ezetimibe. In the HIJ-PROPER study, 1734 ACS patients with dysli...
Main Authors: | Jihaeng Im, Erisa Kawada-Watanabe, Junichi Yamaguchi, Hiroyuki Arashi, Hisao Otsuki, Yuko Matsui, Haruki Sekiguchi, Shinya Fujii, Fumiaki Mori, Hiroshi Ogawa, Nobuhisa Hagiwara |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-87098-x |
Similar Items
-
Effects of Statin versus the Combination of Ezetimibe plus Statin on Serum Lipid Absorption Markers in Patients with Acute Coronary Syndrome
by: Erisa Watanabe, et al.
Published: (2015-01-01) -
New possible pharmacological targets for statins and ezetimibe
by: Mateusz Niedzielski, et al.
Published: (2020-09-01) -
Statin and Ezetimibe Combination Therapy Decreases Mean Platelet Volume Compared to Statin Monotherapy
by: Jun-beom Lee, et al.
Published: (2017-01-01) -
Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers
by: Na-Qiong Wu, et al.
Published: (2018-11-01) -
The combination of Ezetimibe and Statin: a new treatment for hypercholesterolemia
by: Livio Dei Cas, et al.
Published: (2009-08-01)